Search Results - Rosenheck, Hanna

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer

    Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer by Fountzilas, Christos, Bajor, David L, Mukherjee, Sarbajit, Saltzman, Joel, Witkiewicz, Agnieszka K, Maguire, Orla, Minderman, Hans, Nambiar, Ram, Rosenheck, Hanna R, Knudsen, Erik S, Muhitch, Jason B, Abrams, Scott I, Wang, Chong, Hutson, Alan D, Attwood, Kristopher, Hicks, Karen A, Jurcevic, Jennifer A, Kalinski, Pawel, Iyer, Renuka, Boland, Patrick M

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation

    Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation by Mohammadpour, Hemn, Tsuji, Takemasa, MacDonald, Cameron R., Sarow, Joseph L., Rosenheck, Hanna, Daneshmandi, Saeed, Choi, Jee Eun, Qiu, Jingxin, Matsuzaki, Junko, Witkiewicz, Agnieszka K., Attwood, Kristopher, Blazar, Bruce R., Odunsi, Kunle, Repasky, Elizabeth A., McCarthy, Philip L.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    RB loss determines selective resistance and novel vulnerabilities in ER-positive breast cancer models

    RB loss determines selective resistance and novel vulnerabilities in ER-positive breast cancer models by Kumarasamy, Vishnu, Nambiar, Ram, Wang, Jianxin, Rosenheck, Hanna, Witkiewicz, Agnieszka K., Knudsen, Erik S.

    Published in Oncogene
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    CDK/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilities

    CDK/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilities by Knudsen, Erik S., Kumarasamy, Vishnu, Nambiar, Ram, Pearson, Joel D., Vail, Paris, Rosenheck, Hanna, Wang, Jianxin, Eng, Kevin, Bremner, Rod, Schramek, Daniel, Rubin, Seth M., Welm, Alana L., Witkiewicz, Agnieszka K.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: